Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report) crossed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $155.11 and traded as high as $157.92. SPDR S&P Biotech ETF shares last traded at $156.90, with a volume of 8,885,297 shares traded.
SPDR S&P Biotech ETF Trading Up 3.1%
The stock has a market capitalization of $10.59 billion, a price-to-earnings ratio of 11.47 and a beta of 0.87. The stock has a 50-day moving average price of $155.11 and a 200 day moving average price of $142.43.
Hedge Funds Weigh In On SPDR S&P Biotech ETF
A number of hedge funds have recently bought and sold shares of the business. Angeles Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $28,000. Signature Equity Partners LLC lifted its position in shares of SPDR S&P Biotech ETF by 1,285.7% during the 3rd quarter. Signature Equity Partners LLC now owns 194 shares of the exchange traded fund’s stock valued at $31,000 after buying an additional 180 shares in the last quarter. Root Financial Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at approximately $31,000. Axiom Investment Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at approximately $26,000. Finally, Morling Financial Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at approximately $36,000.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
